100% Secure Payments
Tender Details
- Country: USA
- Summary: Ninds Exploratory Clinical Trials (Ug3/Uh3 Clinical Trial Required)
- UST Ref No: 65531771
- Deadline: 10 Mar 2025
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-142
- Purchaser's Detail :
- Description :
- Tender are invited for NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Mar 10, 2025
Posted Date : Apr 18, 2022
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may include Phase 1 and 2 studies of drugs and biologics, feasibility studies of devices, and early studies of surgical, behavioral or rehabilitation therapies. All exploratory trials must contribute to the justification for and provide some of the data required to inform a future trial to establish efficacy (such as a Phase 3, Phase 4 or Pivotal trial). This FOA uses the UG3/UH3 mechanism. Only projects that provide satisfactory progress in the UG3 phase may move to the UH3 phase, as outlined below. For a drug, biologic or device that has not completed a Phase 1/Early Feasibility trial: The UG3 mechanism will be used to plan and execute the Phase I trial(s). If Phase 1 trials are successful, the UG3 will also include the planning phase of a Phase 2 trial. The UH3 mechanism will then support the execut... - Documents :
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterOERWebmaster03@od.nih.gov
Email :OERWebmaster03@od.nih.gov
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
